These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11594575)

  • 1. The effect of insulin-dependent diabetes mellitus on the efficacy of extracorporeal photopheresis in late-stage Sézary syndrome.
    Bouwhuis SA; El Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
    Ann N Y Acad Sci; 2001 Sep; 941():206-9. PubMed ID: 11594575
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis in patients with Sézary syndrome.
    Bouwhuis SA; el-Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
    J Am Acad Dermatol; 2002 Jul; 47(1):63-7. PubMed ID: 12077583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.
    Arulogun S; Prince HM; Gambell P; Lade S; Ryan G; Eaton E; McCormack C
    J Am Acad Dermatol; 2008 Oct; 59(4):589-95. PubMed ID: 18656282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sézary syndrome, cutaneous T-cell lymphoma, and extracorporeal photopheresis.
    Edelson RL
    Arch Dermatol; 1999 May; 135(5):600-1. PubMed ID: 10328207
    [No Abstract]   [Full Text] [Related]  

  • 5. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis in Sézary syndrome.
    Russell-Jones R; Fraser-Andrews E; Spittle M; Whittaker S
    Lancet; 1997 Sep; 350(9081):886. PubMed ID: 9310623
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy.
    Macheiner W; Jantschitsch C; Graninger W; Pálóczy K; Bálint G; Marschalkó M; Kainberger F; Breier F; Knobler RM
    J Am Acad Dermatol; 2003 Feb; 48(2):220-6. PubMed ID: 12582392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.
    Rubio-Muniz CA; Sánchez-Velázquez A; Arroyo-Andrés J; Agud-de Dios M; Tarín-Vicente EJ; Falkenhain-López D; Ortiz-Romero PL
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e102-e105. PubMed ID: 37611255
    [No Abstract]   [Full Text] [Related]  

  • 10. Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.
    Fraser-Andrews E; Seed P; Whittaker S; Russell-Jones R
    Arch Dermatol; 1998 Aug; 134(8):1001-5. PubMed ID: 9722731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.
    McGinnis KS; Ubriani R; Newton S; Junkins-Hopkins JM; Vittorio CC; Kim EJ; Wysocka M; Rook AH
    Arch Dermatol; 2005 Sep; 141(9):1176-8. PubMed ID: 16172331
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome.
    Fritz TM; Kleinhans M; Nestle FO; Burg G; Dummer R
    Br J Dermatol; 1999 Jun; 140(6):1144-7. PubMed ID: 10354086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photopheresis in the red man or pre-Sézary syndrome.
    Zachariae H; Bjerring P; Brodthagen U; Søgaard H
    Dermatology; 1995; 190(2):132-5. PubMed ID: 7727834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal photopheresis in the therapy of Sézary syndrome].
    Marschalkó M; Knobler R; Soós G; Berecz M; Pálóczy K; Rácz I
    Orv Hetil; 1993 Jun; 134(23):1253-7. PubMed ID: 8332344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemia in a patient with advanced Sezary syndrome.
    Anagnostis P; Vakalopoulou S; Slavakis A; Simoulidou E; Rakitzi P; Garipidou V; Harsoulis F
    Leuk Lymphoma; 2009 Feb; 50(2):284-6. PubMed ID: 19160123
    [No Abstract]   [Full Text] [Related]  

  • 16. [The past, present and future of extracorporeal photopheresis].
    Heshmati F
    Ann Dermatol Venereol; 2020 Feb; 147(2):83-85. PubMed ID: 31753524
    [No Abstract]   [Full Text] [Related]  

  • 17. Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma.
    McGirt LY; Baerenwald DA; Vonderheid EC; Eischen CM
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2269-71. PubMed ID: 24909834
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
    Sanli H; Akay BN; Anadolu R; Ozcan M; Saral S; Akyol A
    J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
    Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single-centre experience.
    Atzmony L; Amitay-Laish I; Gurion R; Shahal-Zimra Y; Hodak E
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2382-9. PubMed ID: 26299651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.